EBV EBNA3A (379-387)

EBV EBNA3A (379-387) is an antigenic epitope that may elicit the latent-specific CD8+ T cell response in HLA-B*07:02+ individuals[1].

Product Specifications

CAS Number

[160790-25-0]

UNSPSC

12352209

Target

EBV

Type

Peptides

Related Pathways

Anti-infection

Field of Research

Infection; Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/ebv-ebna3a-379-387.html

Smiles

O=C(N1[C@@H](CCC1)C(N2[C@@H](CCC2)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CC3=CC=CC=C3)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC(C)C)C(O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CCCNC(N)=N)N

Molecular Formula

C55H94N18O10

Molecular Weight

1167.45

References & Citations

[1]Rowntree LC, et al. A Shared TCR Bias toward an Immunogenic EBV Epitope Dominates in HLA-B*07:02-Expressing Individuals. J Immunol. 2020 Sep 15;205 (6) :1524-1534. |[2]Rowntree LC, et al. A Shared TCR Bias toward an Immunogenic EBV Epitope Dominates in HLA-B*07:02-Expressing Individuals. J Immunol. 2020 Sep 15;205 (6) :1524-1534.